Evidence map›Paper›PMID 42588094›Full record

ArticleNutrients2026

Obesogenic Diets Composition Differentially Alters the

Mayra Montecillo-Aguado, Esmeralda Rodríguez-Miranda, Guillermina Baay-Gúzman, Juana Rosalba Garcia-Ramirez, Daniel Hernández-Cueto, Sergio López-Briones, Marco Antonio Hernández-Luna

Abstract read
In one paragraph

Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mayra Montecillo-AguadoLaboratorio de Biomedicina Traslacional, Departamento de Medicina y Nutrición, Universidad de Guanajuato, León 37670, Guanajuato, Mexico.
Esmeralda Rodríguez-MirandaLaboratorio de Biomedicina Traslacional, Departamento de Medicina y Nutrición, Universidad de Guanajuato, León 37670, Guanajuato, Mexico.
Guillermina Baay-GúzmanUnidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México, Federico Gómez, Ciudad de México 06720, Mexico.ORCID 0000-0002-8204-6285
Juana Rosalba Garcia-RamirezDepartamento de Medicina y Nutrición, Universidad de Guanajuato, León 37670, Guanajuato, Mexico.ORCID 0000-0003-2773-3290
Daniel Hernández-CuetoUnidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México, Federico Gómez, Ciudad de México 06720, Mexico.ORCID 0000-0001-9338-6368
Sergio López-BrionesLaboratorio de Biomedicina Traslacional, Departamento de Medicina y Nutrición, Universidad de Guanajuato, León 37670, Guanajuato, Mexico.
Marco Antonio Hernández-LunaLaboratorio de Biomedicina Traslacional, Departamento de Medicina y Nutrición, Universidad de Guanajuato, León 37670, Guanajuato, Mexico.ORCID 0000-0002-1767-5720

Funding

Secretaría de Ciencia, Humanidades, Tecnología e InnovaciónCONACYT CF-2023-G-520
6 · The paper itself

Abstract

backgroundDiets high in fat and carbohydrates, like fructose, trigger colon inflammation, increase intestinal permeability, and drive dysbiosis. However, the effects of obesogenic diets on gut microbiota, including

methodsUsing a controlled preclinical obesity model, we compared the effects over time of High-Fat Diet (HFD), High-Fructose Diet (HFrD), and their combination (HFHFrD). Diet-induced dysbiosis was assessed at 4 and 8 weeks via qPCR using primers specific to bacterial phyla and species. In addition, intestinal inflammation, atrophy, and mucin production were evaluated by digital pathology after 8 weeks of diet exposure.

resultsboth HFrD and HFHFrD mice exhibited marked intestinal inflammation, atrophy, and damage, alongside altered production of neutral and mixed mucins. HFD-fed mice displayed a 15-fold surge in

conclusionsAlthough all obesogenic diets induced inflammation, atrophy, epithelial damage, and altered mucin patterns, HFrD and HFHFrD caused pronounced disruptions to barrier function and dysbiosis. Critically, HFD consistently raised the Firmicutes/Bacteroidetes ratio at 4 and 8 weeks, while the

Indexed as

BacteroidesClostridiumColitisColonDiet, High-FatGastrointestinal MicrobiomeObesityAnimalsDysbiosisFructoseInflammationIntestinal Barrier FunctionMaleMiceMice, Inbred C57BLMucinsFructoseMucinsBacteroidesClostridiumcoloninflammationintestinal microbiotamucinsobesogenic diets

Identifiers

PMID42588094
PMCPMC13468517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.